Showing results (2301-2310 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|May 23, 2007
Dimethylamino-functionalised and N-heteroaryl-substituted titanocene anticancer drugs: synthesis and cytotoxicity studiesThomas Hickey, James Claffey, Eoin Fitzpatrick, et al.
Investigational New Drugs|May 1, 1990
Phase I trial of tallysomycin S10b, a bleomycin analogueF P Paolozzi, R C Gaver, N B Newman, et al.
Investigational New Drugs|July 13, 2006
A phase II trial of 17-(Allylamino)-17-demethoxygeldanamycin in patients with papillary and clear cell renal cell carcinomaEllen A Ronnen, G Varuni Kondagunta, Nicole Ishill, et al.
Investigational New Drugs|July 10, 2008
Trastuzumab induces gastrointestinal side effects in HER2-overexpressing breast cancer patientsNoor Al-Dasooqi, Joanne M Bowen, Rachel J Gibson, et al.
Investigational New Drugs|July 12, 2008
A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancerHedy Lee Kindler, Howard A Burris, Alan B Sandler, et al.
Investigational New Drugs|July 12, 2008
A phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapyChristopher Lieu, Laura Chow, A Scott Pierson, et al.
Investigational New Drugs|July 16, 2008
Phase I trial of weekly docetaxel and daily temozolomide in patients with metastatic diseaseI Tamaskar, T Mekhail, R Dreicer, et al.
Investigational New Drugs|October 26, 2007
Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancerGeorge R Blumenschein, Merrill S Kies, Vassiliki A Papadimitrakopoulou, et al.
Investigational New Drugs|July 30, 2008
Level of HER2/neu gene amplification as a predictive factor of response to trastuzumab-based therapy in patients with HER2-positive metastatic breast cancerGiuseppe Gullo, Daniela Bettio, Valter Torri, et al.
Investigational New Drugs|July 31, 2008
Bowel perforation in non-small cell lung cancer after bevacizumab therapyElisabeth Schellhaas, Christoph Loddenkemper, Alexander Schmittel, et al.
Pageof 372